home / stock / bdsx / bdsx news


BDSX News and Press, Biodesix Inc.

Stock Information

Company Name: Biodesix Inc.
Stock Symbol: BDSX
Market: NASDAQ
Website: biodesix.com

Menu

Get BDSX Alerts

News, Short Squeeze, Breakout and More Instantly...

BDSX - Biodesix Recognized as a Top Workplace for Third Consecutive Year

LOUISVILLE, Colo., April 09, 2026 (GLOBE NEWSWIRE) -- Biodesix is proud to announce that it has earned the prestigious 2026 USA TODAY Top Workplaces award. The award honors organizations with 150+ employees that have created  exceptional, people-first cultures . The winners are determined ...

BDSX - Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development

LOUISVILLE, Colo., April 06, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that the company will present seven abstracts, including two oral sessions, at the American Association for Cancer Research (AACR) Annual Meeting in San Di...

BDSX - Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer Diagnosis

LOUISVILLE, Colo., March 20, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, announced the publication of the largest lung nodule biomarker clinical validation study ever conducted . This milestone strengthens the clinical foundation for Nodify ...

BDSX - Biodesix, Inc. (BDSX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

2026-03-11 13:52:22 ET Biodesix, Inc. (BDSX) Barclays 28th Annual Global Healthcare Conference March 11, 2026 12:00 PM EDT... Read the full article on Seeking Alpha For further details see: Biodesix, Inc. (BDSX) Presents at Barclays 28th Annual Global Healthcare Conference T...

BDSX - Outperform Recommendation Issued On BDSX By William Blair

2026-02-27 01:15:03 ET William Blair analyst issues OUTPERFORM recommendation for BDSX on February 27, 2026 06:03AM ET. The previous analyst recommendation was Market Perform. BDSX was trading at $14.22 at issue of the analyst recommendation. The overall analyst consensu...

BDSX - Biodesix outlines $106M-$112M 2026 revenue target as sales expansion drives 41% Q4 growth

2026-02-26 21:18:35 ET More on Biodesix Biodesix, Inc. (BDSX) Q4 2025 Earnings Call Transcript Biodesix skyrockets 43%, expects FY revenue to beat guidance Seeking Alpha’s Quant Rating on Biodesix Historical earnings data for Biodesix Financial...

BDSX - Biodesix, Inc. (BDSX) Q4 2025 Earnings Call Transcript

2026-02-26 21:17:46 ET Biodesix, Inc. (BDSX) Q4 2025 Earnings Call February 26, 2026 4:30 PM EST Company Participants Scott Hutton - President, CEO & Director Robin Cowie - CFO, Secretary & Treasurer ... Read the full article on Seeking Alpha For ...

BDSX - Biodesix (BDSX) Q4 2025 Earnings Call Transcript

2026-02-26 19:14:05 ET Image source: The Motley Fool. Feb. 26, 2026, at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

BDSX - Biodesix GAAP EPS of -$0.49 beats by $0.38, revenue of $28.7M beats by $2.45M

2026-02-26 17:04:50 ET More on Biodesix Biodesix skyrockets 43%, expects FY revenue to beat guidance Seeking Alpha’s Quant Rating on Biodesix Historical earnings data for Biodesix Financial information for Biodesix Read the full article on Se...

BDSX - Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights

Delivered 41% revenue growth and 83% gross margin in Q4 2025; Improved Net Loss by 52% and achieved first-ever Adjusted EBITDA positivity in Q4 2025; FY2026 Revenue Guidance of $106-112 million, mid-point reflects 23% growth; Conference Call and Webcast Today at 4:30 p.m. ET LOUIS...

Next 10